STATE COLLEGE, PA, UNITED STATES, July 29, 2025 /EINPresswire / -- INDIGO Biosciences, a global leader in cell-based assay solutions, announced today the expansion of its alternative species line with ...

A potential new male contraceptive drug has just undergone its first tests in human volunteers. The results give the first ...

ACCURATELY predicting which breast cancer patients will respond completely to neoadjuvant chemotherapy (NAC) remains a ...

New research is showing promise that a vaccine may be able to fight one type of the most common cancers in women. Phase one ...

A Northeastern University researcher has identified a way to target two of the deadliest cancer types, melanoma and triple ...

A novel triple therapy shows promise for advanced triple-negative breast cancer, offering hope for patients with limited treatment options.

The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...

Spanish researchers have achieved a significant breakthrough in the fight against the deadliest form of breast ...

No one wants to hear the words: "You have cancer." But about 1 in 8 American women will learn they have breast cancer, according to the Centers for Disease Control and Prevention. "Breast ...

Are you struggling with bone and joint pain after 45? Experts reveal why menopause hurts your body—and what you can do to ...

It suddenly dawned at her that she had not. Menopause is a phase which every woman around the age of 45-55 experiences. It is ...